Literature DB >> 3654482

Cytoplasmic suppression of malignancy.

B A Israel1, W I Schaeffer.   

Abstract

Using both normal and transformed rat liver epithelial cells to prepare cytoplasmic hybrids (cybrids) we have found evidence to support the theory that the cytoplasm from a normal cell can suppress tumorigenicity. A unique aspect of this study is that all of the cells utilized, both normal and malignantly transformed, were derived from an original cloned cell. We found that fusing cytoplasts from normal cells to malignantly transformed whole cells resulted in cybrid clones which, when injected into newborn rat pups, isogenic with those from which the cell culture was initiated, yielded tumors in 51% of the animals injected compared to 92% of the animals injected with the tumorigenic parent. Those animals that did develop tumors from the cybrid cells survived longer than those injected with cells from the tumorigenic parent. Thus, the cybrid, formed of cytoplasm from both parents, was less tumorigenic than the malignantly transformed parent cell. When reconstituted cells were prepared by fusing cytoplasts from normal cells with karyoplasts from malignantly transformed cells, a situation in which essentially all of the cytoplasm of the reconstituted cell is derived from normal cells, the tumorigenic phenotype was extinguished.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654482     DOI: 10.1007/bf02621071

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  27 in total

1.  Noncoordinate expression of SV40-induced transformation and tumorigenicity in mouse cell hybrids.

Authors:  N Howell; R Sager
Journal:  Somatic Cell Genet       Date:  1979-01

2.  Identification of mitochondrial DNA species in interspecific cybrids and reconstituted cells using restriction endonuclease.

Authors:  J Hayashi; O Gotoh; Y Tagashira; M Tosu; T Sekiguchi
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

Review 3.  Cytoplasmic modification of nuclear gene expression.

Authors:  J W Shay
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

4.  Pigmentation and tumorigenicity of reconstituted, cybrid and hybrid mouse cells.

Authors:  R Halaban; G Moellmann; E Godawska; J M Eisenstadt
Journal:  Exp Cell Res       Date:  1980-12       Impact factor: 3.905

5.  Suppression of tumorigenicity in interspecific reconstituted cells and cybrids.

Authors:  M Koura; H Isaka; M C Yoshida; M Tosu; T Sekiguchi
Journal:  Gan       Date:  1982-08

6.  Isolation and characterization of intraspecific cybrids. Effect of mitochondrial DNA on their cellular properties.

Authors:  J Hayashi; Y Tagashira; H Higashida; S Hirai; M C Yoshida; T Sekiguchi
Journal:  Exp Cell Res       Date:  1984-10       Impact factor: 3.905

7.  The long-term culture of a diploid rat hepatocyte cell strain.

Authors:  W I Schaeffer
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Diploid azaguanine-resistant mutants of cultured human fibroblasts.

Authors:  R J Albertini; R Demars
Journal:  Science       Date:  1970-07-31       Impact factor: 47.728

9.  Cytoplasmic effects on the tissue culture response of wheat (Triticum aestivum) callus.

Authors:  R J Mathias; K Fukui; C N Law
Journal:  Theor Appl Genet       Date:  1986-04       Impact factor: 5.699

10.  5-Azacytidine-induced uncoupling of differentiation and tumorigenicity in a murine cell line.

Authors:  C Walker; D F Ranney; J W Shay
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

View more
  10 in total

1.  Cytoplasmic mediation of malignancy.

Authors:  B A Israel; W I Schaeffer
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

2.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 3.  Cell fusion in cancer hallmarks: Current research status and future indications.

Authors:  Hao-Fei Wang; Wei Xiang; Bing-Zhou Xue; Yi-Hao Wang; Dong-Ye Yi; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

4.  Cancer stem cell theory and the warburg effect, two sides of the same coin?

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

Review 5.  Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

Authors:  B Poljsak; V Kovac; R Dahmane; T Levec; A Starc
Journal:  Oxid Med Cell Longev       Date:  2019-10-08       Impact factor: 6.543

Review 6.  Updated Understanding of Cancer as a Metabolic and Telomere-Driven Disease, and Proposal for Complex Personalized Treatment, a Hypothesis.

Authors:  Cristian Muresanu; Siva G Somasundaram; Sergey V Vissarionov; Luis Fernando Torres Solis; Arturo Solís Herrera; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 7.  The Role of Mitochondrial miRNAs in the Development of Radon-Induced Lung Cancer.

Authors:  Assiya Kussainova; Olga Bulgakova; Akmaral Aripova; Zumama Khalid; Rakhmetkazhi Bersimbaev; Alberto Izzotti
Journal:  Biomedicines       Date:  2022-02-11

8.  Cancer as a mitochondrial metabolic disease.

Authors:  Thomas N Seyfried
Journal:  Front Cell Dev Biol       Date:  2015-07-07

Review 9.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

Review 10.  Aging, Metabolism, and Cancer Development: from Peto's Paradox to the Warburg Effect.

Authors:  Tia R Tidwell; Kjetil Søreide; Hanne R Hagland
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.